期刊文献+

Matrix metalloproteinase 13,a new target for therapy in Alzheimer’s disease

原文传递
导出
摘要 Alzheimer’s disease(AD),the most common neurodegenerative disorder,affects millions of people worldwide.In a recent publication,Guo-Jun Chen and colleagues highlight the role of matrix metalloproteinase(MMP)13(also called Collagenase 3)in AD pathogenesis through regulating BACE1,1 a rate-limiting enzyme for b-amyloid(Ab)peptide production.2 Proteolytic processing of amyloid precursor protein(APP)by BACE1 and g-secretase generates Ab,which accumulate in brain senile plaques in AD.3 MMPs are a group of enzymes that degrade extracellular matrix and cleave proteins involved in signal transduction.
出处 《Genes & Diseases》 SCIE 2019年第1期1-2,共2页 基因与疾病(英文)
基金 Research in the Thinakaran laboratory is supported by the United States Department of Health and Human Services,National Institutes of Health grants AG054223,AG056061,and AG057290.
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部